Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;96(3):114876.
doi: 10.1016/j.diagmicrobio.2019.114876. Epub 2019 Jul 31.

The risk factors associated with MERS-CoV patient fatality: A global survey

Jamal Ahmadzadeh  1 , Kazhal Mobaraki  1 , Seyed Jalil Mousavi  2 , Javad Aghazadeh-Attari  1 , Mohammad Mirza-Aghazadeh-Attari  3 , Iraj Mohebbi  4
Affiliations

The risk factors associated with MERS-CoV patient fatality: A global survey

Jamal Ahmadzadeh et al. Diagn Microbiol Infect Dis. 2020 Mar.

Abstract

Risk factors associated with Middle East respiratory syndrome coronavirus (MERS-CoV) infection outcome were established by analyses of WHO data from September 23, 2012 to 18 June 2018. Of the 2220 reported cases, 1408 cases, including 451 MERS-CoV deaths, were analyzed. The case fatality rate was 32% (95% CI: 29.4-34.5). Compared to MERS patients ≤30 years old, those with >30 years had the adjusted odds ratio estimate for death of 2.38 [95% CI: 1.75-3.22]. This index was 1.43 [95% CI: 1.06-1.92] for Saudi patients in comparison to non-Saudi; 1.76 [95% CI: 1.39-2.22] for patient with comorbidity in comparison to those without comorbidity; 0.58 [95% CI: 0.44-0.75] for those who had close contact to a camel in the past 14 days and 0.42 [95% CI: 0.31-0.57] for patients with >14 days with onset of signs and hospital admission compared to patients with ≤14 days.

Keywords: Case fatality rate; Emerging infectious disease; Epidemiology; Middle East respiratory syndrome coronavirus.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare that they have no competing interests.

References

    1. Cowling B.J., Park M., Fang V.J., Wu P., Leung G.M., Wu J.T. Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May–June 2015. Euro surveillance: bulletin Europeen sur les maladies transmissibles – European communicable disease bulletin. 2015;20(25) - PubMed
    1. Alamoudi R.J., Azhar L.E., Alamoudi D.H., Alamoudi D.H., Tolah A.M., Alhabbab R.Y. No molecular evidence of MERS-CoV circulation in Jeddah, Saudi Arabia between 2010–2012: a single-center retrospective study. The Journal of Infection in Developing Countries. 2018;12(05):390–393. - PubMed
    1. Alghamdi I.G., Hussain I.I., Almalki S.S., Alghamdi M.S., Alghamdi M.M., El-Sheemy M.A. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. International journal of general medicine. 2014;7:417. - PMC - PubMed
    1. Alraddadi B.M., Al-Salmi H.S., Jacobs-Slifka K., Slayton R.B., Estivariz C.F., Geller A.I. Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel. Emerg Infect Dis. 2016;22(11):1915. - PMC - PubMed
    1. Alshahrani M.S., Sindi A., Alshamsi F., Al-Omari A., El Tahan M., Alahmadi B. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care. 2018;8(1):3. - PMC - PubMed